KASID
Current Issue Volume 23(2); April 2025
Intestinal Research
Latest Issue: Volume 23 Issue 2
Editor-in-Chief: Toshifumi Hibi
Print ISSN: 1598-9100
Online ISSN: 2288-1956
Online ISSN: 2288-1956
Frequency: Quarterly
Impact Factor: 3.9
Gastroenterology & Hepatology - Q2 (38/147)
Impact Factor: 3.9
Gastroenterology & Hepatology - Q2 (38/147)
, Ye-Jee Kim
, Kei Moriya
- MOST CITED
-
- Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis44
- Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease35
- Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease29
- Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer24
- MOST VIEWED
-
- Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease12,785
- Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis12,362
- Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer10,151
- Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases10,053
- AHEAD OF PRINT
-
- Cross-ethnic evaluation of gut microbial signatures reveal increased colonization with oral pathobionts in the north Indian inflammatory bowel disease cohort
- Efficacy and safety of carotegrast methyl in active ulcerative colitis: a real-world prospective cohort study
- Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study
- Ulcerative colitis disease severity affects the speed of symptom relief under filgotinib treatment: a post hoc analysis of the phase 2b/3 SELECTION study
